These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Polycystic kidney disease and angiotensin-converting enzyme inhibitors. Bursztyn M Ann Intern Med; 1992 Jul; 117(1):90. PubMed ID: 1596054 [No Abstract] [Full Text] [Related]
8. The diabetic with renal impairment. Tallis GA; Phillips PJ; Popplewell PY Aust Fam Physician; 1997 Sep; 26(9):1091-2. PubMed ID: 9382724 [No Abstract] [Full Text] [Related]
9. Severe reduction of renal function in hypertensives and/or diabetics induced by angiotensin-converting enzyme inhibitors. Gotloib L; Jaichenko S; Fudin R; Shostok A Nephron; 1995; 71(2):230-1. PubMed ID: 8569962 [No Abstract] [Full Text] [Related]
10. [Angiotensin-converting enzyme inhibitors. Principles and rules of use]. Eicher JC; Wolf JE Rev Prat; 1998 Apr; 48(7):771-6. PubMed ID: 11767373 [No Abstract] [Full Text] [Related]
11. [Hypertension and diabetic nephropathy, a dangerous duo]. Hausberg M; Hohage H; Kosch M Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181 [No Abstract] [Full Text] [Related]
12. Systolic hypertension; diabetes mellitus; renal dysfunction; and the use of ACE inhibitors in African-American population. Wurtzbacher JD; Gourley GA; Cushman WC; Fine D; Miller J; Shane R; Schultz K Am J Manag Care; 2000 Feb; 6(3 Suppl):S141-3. PubMed ID: 10977445 [No Abstract] [Full Text] [Related]
13. [Angiotensin converting enzyme inhibitors in the treatment of diabetes]. Smahelová A Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161 [No Abstract] [Full Text] [Related]
14. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics. Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973 [No Abstract] [Full Text] [Related]
15. Reversible impairment of renal function associated with enalapril in a diabetic patient. Albareda MM; Corcoy R CMAJ; 1998 Nov; 159(10):1279-81. PubMed ID: 9861226 [TBL] [Abstract][Full Text] [Related]
17. The end of the road for dual renin-angiotensin system blockade in diabetic nephropathy: which way now? Advani A Can J Diabetes; 2014 Oct; 38(5):292-5. PubMed ID: 25172268 [No Abstract] [Full Text] [Related]
18. [Control of arterial pressure in diabetic nephropathy]. Luño J; García de Vinuesa S Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304 [No Abstract] [Full Text] [Related]
20. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. Kalra PA; Kumwenda M; MacDowall P; Roland MO BMJ; 1999 Jan; 318(7178):234-7. PubMed ID: 9915733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]